Standard BioTools Income After Taxes 2012-2026 | LAB
Standard BioTools income after taxes from 2012 to 2026. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
|
Standard BioTools Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2025 | $-59 |
| 2024 | $-139 |
| 2023 | $-75 |
| 2022 | $-190 |
| 2021 | $-59 |
| 2020 | $-53 |
| 2019 | $-65 |
| 2018 | $-59 |
| 2017 | $-61 |
| 2016 | $-76 |
| 2015 | $-53 |
| 2014 | $-53 |
| 2013 | $-17 |
| 2012 | $-19 |
| 2011 | $-22 |
|
Standard BioTools Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2026-03-31 | $-15 |
| 2025-12-31 | $17 |
| 2025-09-30 | $-32 |
| 2025-06-30 | $-18 |
| 2025-03-31 | $-26 |
| 2024-12-31 | $-59 |
| 2024-09-30 | $-22 |
| 2024-06-30 | $-25 |
| 2024-03-31 | $-32 |
| 2023-12-31 | $-20 |
| 2023-09-30 | $-21 |
| 2023-06-30 | $-17 |
| 2023-03-31 | $-17 |
| 2022-12-31 | $-21 |
| 2022-09-30 | $-29 |
| 2022-06-30 | $-64 |
| 2022-03-31 | $-76 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-19 |
| 2020-12-31 | $-18 |
| 2020-09-30 | $-6 |
| 2020-06-30 | $-13 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-13 |
| 2019-09-30 | $-13 |
| 2019-06-30 | $-14 |
| 2019-03-31 | $-25 |
| 2018-12-31 | $-15 |
| 2018-09-30 | $-15 |
| 2018-06-30 | $-16 |
| 2018-03-31 | $-13 |
| 2017-12-31 | $-10 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-17 |
| 2017-03-31 | $-17 |
| 2016-12-31 | $-18 |
| 2016-09-30 | $-20 |
| 2016-06-30 | $-19 |
| 2016-03-31 | $-20 |
| 2015-12-31 | $-13 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-16 |
| 2014-12-31 | $-11 |
| 2014-09-30 | $-14 |
| 2014-06-30 | $-13 |
| 2014-03-31 | $-15 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $-4 |
| 2012-09-30 | $-4 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-7 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.324B | $0.085B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.903B | 26.57 |
| Tempus AI (TEM) | United States | $9.129B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.210B | 295.58 |
| Hinge Health (HNGE) | United States | $5.372B | 0.00 |
| 10x Genomics (TXG) | United States | $4.412B | 0.00 |
| Doximity (DOCS) | United States | $3.742B | 19.67 |
| IRhythm Holdings (IRTC) | United States | $3.439B | 0.00 |
| Privia Health (PRVA) | United States | $2.983B | 147.94 |
| Heartflow (HTFL) | United States | $2.901B | 0.00 |
| Clover Health Investments (CLOV) | United States | $2.633B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.266B | 0.00 |
| Omnicell (OMCL) | United States | $1.776B | 36.16 |
| Enovis (ENOV) | United States | $1.265B | 6.50 |
| Inspire Medical Systems (INSP) | United States | $1.228B | 16.52 |
| Schrodinger (SDGR) | United States | $1.163B | 0.00 |
| Azenta (AZTA) | United States | $1.074B | 51.80 |
| Talkspace (TALK) | United States | $0.873B | 521.00 |
| Veradigm (MDRX) | United States | $0.587B | 0.00 |
| Phreesia (PHR) | United States | $0.580B | 33.50 |
| Fulgent Genetics (FLGT) | United States | $0.511B | 0.00 |
| Evolent Health (EVH) | United States | $0.505B | 0.00 |
| Claritev (CTEV) | United States | $0.502B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.392B | 0.00 |
| TruBridge (TBRG) | United States | $0.391B | 11.34 |
| CapsoVision (CV) | United States | $0.330B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.282B | 0.00 |
| Carlsmed (CARL) | United States | $0.274B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.179B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.176B | 0.00 |
| American Well (AMWL) | United States | $0.140B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| Outset Medical (OM) | United States | $0.094B | 0.00 |
| CareCloud (CCLD) | United States | $0.093B | 6.61 |
| P3 Health Partners (PIII) | United States | $0.078B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.071B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.054B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.040B | 0.00 |
| 111 (YI) | China | $0.039B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.027B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.000B | 0.00 |